It is going to be an interesting couple of months.
I got the impression that when they brought down sales guidance for the year they were belt and bracing it. On the call they alluded to the possibility of sales coming in higher if certain things fell into place. For me the key will be what sales forecast they give for next year and what progress they make with respect to the public healthcare providers. The NHS trial will take a little longer but you would hope to see some progress in more NZ regions and we know they have trialed/ are in trials with at least 2 public screening programs in Aus.
Management is good, product is unrivalled and they are looking to expand in to interesting new areas.
